The Use of Synthetic Carriers in Malaria Vaccine Design
Malaria vaccine research has been ongoing since the 1980s with limited success. However, recent improvements in our understanding of the immune responses required to combat each stage of infection will allow for intelligent design of both antigens and their associated delivery vaccine vehicles/vect...
Main Authors: | Liam Powles, Sue D. Xiang, Cordelia Selomulya, Magdalena Plebanski |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-10-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | http://www.mdpi.com/2076-393X/3/4/894 |
Similar Items
-
Pullulan-Coated Iron Oxide Nanoparticles for Blood-Stage Malaria Vaccine Delivery
by: Liam Powles, et al.
Published: (2020-11-01) -
Magnetic Nanovectors for the Development of DNA Blood-Stage Malaria Vaccines
by: Fatin M. Nawwab Al-Deen, et al.
Published: (2017-02-01) -
A Synthetic Nanoparticle Based Vaccine Approach Targeting MSP4/5 Is Immunogenic and Induces Moderate Protection Against Murine Blood-Stage Malaria
by: Kirsty L. Wilson, et al.
Published: (2019-03-01) -
Development of a durable and efficacious pre-erythrocytic malaria vaccine
by: Rudiansyah, I
Published: (2022) -
A model to study the impact of polymorphism driven liver-stage immune evasion by malaria parasites, to help design effective cross-reactive vaccines
by: Kirsty Lee Wilson, et al.
Published: (2016-03-01)